About the Platform
EuropaBio’s Biomanufacturing Platform has the mission to represent biomanufacturing at the highest policy levels in Europe, to ensure that it is visible and recognised within the industrial strategy and Europe’s green and digital transitions.
EuropaBio champions biomanufacturing across its Healthcare, Industrial Biotechnology and National Associations Councils and a cross-sectoral Platform brings these voices together to accelerate Europe’s growth. Examples include:
- EuropaBio 25th Anniversary nominations including manufacture of Vitamin B5, CAR-T cell therapies and butandiol
- Report ‘Measuring the economic footprint of the Biotechnology Industry in Europe’
- Representation within the EC Industrial Forum through TF5 ‘uptake of advanced manufacturing processes by EU industry’
- EFIB conference Vilnius Statement ‘Next generation economies - Industrial Biotechnology for a sustainable society’
EuropaBio’s Biomanufacturing Platform will address the policy and wider frameworks through which biomanufacturing is delivered. Together with members and stakeholders, it will address how economic growth, employment and resilience are achieved through policy, legal frameworks and regulation at EU and national levels.
Opportunities for Members
Platform activities will build an economic evidence-base for biomanufacture across sectors, reflect policy priorities from EuropaBio’s Healthcare, Industrial Biotechnology and National Association Councils and build case studies to demonstrate diversity and impact of biomanufacture.
The Biomanufacturing Platform will host its first policy summit on March 15 in Brussels. The Summit will set the vision for Europe’s global innovation, competitiveness and sustainability through the lens of biomanufacturing and set a baseline for its understanding and recognition within policy.
For all enquiries, please contact Dr Claire Skentelbery firstname.lastname@example.org
The SME Platform has priorities developed with Members for work with Member and external SMEs throughout the year. Priorities in 2021 include:
Policy developments of significance to Healthcare and Industrial Biotechnology SMEsFinancial development pathways for SMEs
SME representation in the 25th EuropaBio Anniversary programme
Presentation of the Start Up City at the European Forum for Industrial Biotechnology